Sep 11, 2024 1:58:04 PM
Highly efficient DNA removal in Viral Vector Manufacturing
In this presentation we will show you how we used our proprietary engineering platform ENESYZ® for...
read more
Jul 30, 2024 11:21:53 AM
Upcoming Webinar: Salt-tolerant endonucleases and the benefits for viral vector manufacturing, and a comparison of two marketed enzymes
Tuesday 27th August 202408:00 PDT / 11:00 EDT / 16:00 BST / 17:00 CEST Live30 webinars are...
read more
Mar 5, 2024 8:48:42 AM
c-LEcta launches DENARASE® High Salt for enhanced process flexibility in Viral Vector Manufacturing
c-LEcta, a leading international supplier of enzymes for the biopharmaceutical industry announces...
read more
Nov 8, 2023 10:37:27 AM
How to compare the technical performance of S. marcescens endonucleases such as DENARASE & Benzonase?
Endonucleases are widely used in the manufacturing of viral vectors for cell and gene therapies....
read more
Sep 13, 2023 11:02:12 AM
c-LEcta increases market presence in the USA
c-LEcta establishes a US warehouse for R&D-grade DENARASE® portfolio and partners with local...
read more
Jun 26, 2023 12:00:00 AM
c-LEcta @ Bioprocessing Summit & BPI Boston
In August and September c-LEcta is presenting their DENARASE® portfolio: DENARASE® for research and...
read more
May 4, 2023 10:31:00 AM
Accelerate the Manufacturing of Gene and Cell Therapies with GMP Enzymes from c-LEcta
During BPI US West in San Diego, our Head of Marketing Raphael Gübeli talked about recent trends...
read more
Apr 19, 2023 11:33:00 AM
US FDA DMF Support for DENARASE® GMP-grade
c-LEcta successfully filed a Drug Master File (Type II) with the US FDA in 2021. We spoke with Dr....
read more
Mar 28, 2023 11:05:00 AM
Kerry and c-LEcta enter agreement to market DENARASE® products
Kerry, a world leader in taste and nutrition, and c-LEcta, a leading biotechnology company in...
read more
Feb 14, 2023 10:54:00 AM
BioProcess International US West, San Diego
From February 27 - March 2, 2023 the BPI US West will take place in San Diego. The BPI US West...
read more